129 related articles for article (PubMed ID: 9853065)
1. [Mucoviscidosis: therapeutic strategies are multiplying].
Clément A; Tamalet A; Fauroux B; Tournier G
Arch Pediatr; 1998 Nov; 5(11):1246-52. PubMed ID: 9853065
[TBL] [Abstract][Full Text] [Related]
2. [New therapeutic approaches to Cystic fibrosis].
Willemot JM; Sermet Gaudelus I; Lenoir G
Ann Pharm Fr; 2003 Jul; 61(4):253-8. PubMed ID: 12843958
[TBL] [Abstract][Full Text] [Related]
3. [Protein repair therapy in cystic fibrosis].
Clément A; Tamalet A; Fauroux B; Epaud R
Rev Prat; 2003 Jan; 53(2):163-6. PubMed ID: 12664848
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.
Rubenstein RC
Mol Diagn Ther; 2006; 10(5):293-301. PubMed ID: 17022692
[TBL] [Abstract][Full Text] [Related]
5. [Cystic fibrosis: new treatments targeting the CFTR protein].
Fajac I; Sermet-Gaudelus I
Rev Mal Respir; 2013 Apr; 30(4):255-61. PubMed ID: 23664284
[TBL] [Abstract][Full Text] [Related]
6. [Gene therapy in mucoviscidosis].
Schatz C; Pavirani A
Rev Pneumol Clin; 1995; 51(3):201-6. PubMed ID: 7569584
[TBL] [Abstract][Full Text] [Related]
7. New treatments targeting the basic defects in cystic fibrosis.
Fajac I; Wainwright CE
Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
[TBL] [Abstract][Full Text] [Related]
8. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee T; Southern KW
Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
[TBL] [Abstract][Full Text] [Related]
9. New therapies in cystic fibrosis.
Ratjen F; Grasemann H
Curr Pharm Des; 2012; 18(5):614-27. PubMed ID: 22229570
[TBL] [Abstract][Full Text] [Related]
10. New horizons for cystic fibrosis treatment.
Fajac I; De Boeck K
Pharmacol Ther; 2017 Feb; 170():205-211. PubMed ID: 27916649
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning.
Barry PJ; Ronan N; Plant BJ
Semin Respir Crit Care Med; 2015 Apr; 36(2):287-98. PubMed ID: 25826594
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy in cystic fibrosis.
Prickett M; Jain M
Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
[TBL] [Abstract][Full Text] [Related]
14. A new era of personalized medicine for cystic fibrosis - at last!
Quon BS; Wilcox PG
Can Respir J; 2015; 22(5):257-60. PubMed ID: 26083544
[TBL] [Abstract][Full Text] [Related]
15. [New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].
Hubert D; Bui S; Marguet C; Colomb-Jung V; Murris-Espin M; Corvol H; Munck A
Rev Mal Respir; 2016 Oct; 33(8):658-665. PubMed ID: 26806675
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies to correct malfunction of CFTR.
Lim M; Zeitlin PL
Paediatr Respir Rev; 2001 Jun; 2(2):159-64. PubMed ID: 12531063
[TBL] [Abstract][Full Text] [Related]
17. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
18. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
Jiang Q; Engelhardt JF
Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
[TBL] [Abstract][Full Text] [Related]
19. [From the laboratory to the clinic: CFTR and the therapeutic options for cystic fibrosis].
Mayol J; Alvarez de Arcaya Vicente A; Arbeo Escolar AM; Peña Soria MJ; Alvarez Fernández-Represa J
An Med Interna; 2000 Feb; 17(2):92-8. PubMed ID: 10829466
[TBL] [Abstract][Full Text] [Related]
20. [Genetic therapy in mucoviscidosis].
Bellon G; Pavirani A
Arch Pediatr; 2000 May; 7 Suppl 2():355s-357s. PubMed ID: 10904772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
